Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for T&R Biofab Co's OCF Margin % or its related term are showing as below:
XKRX:246710'
s OCF Margin % Range Over the Past 10 Years
Min: -944.78 Med: -237.26 Max: -27.68
Current: -6.88
During the past 12 years, the highest OCF Margin % of T&R Biofab Co was -27.68%. The lowest was -944.78%. And the median was -237.26%.
XKRX:246710's OCF Margin % is ranked worse than 69.13% of 813
companies
in the Medical Devices & Instruments industry
Industry Median: 6.48
vs XKRX:246710: -6.88
The historical data trend for T&R Biofab Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:246710 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, T&R Biofab Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
T&R Biofab Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, T&R Biofab Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where T&R Biofab Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
T&R Biofab Co (XKRX:246710) has a OCF Margin % of -11.06% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on T&R Biofab Co and its competitors. According to the industry distribution chart, T&R Biofab Co ranks #562 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 69.1%.
Is T&R Biofab Co's OCF Margin % too high?
T&R Biofab Co's current OCF Margin % is -11.06%. Based on the distribution chart, T&R Biofab Co ranks #562 out of 813 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, T&R Biofab Co has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does T&R Biofab Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, T&R Biofab Co ranks #562 out of 813 companies for OCF Margin %. This places T&R Biofab Co in the lower half of its industry. The industry median OCF Margin % is 6.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.48, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on T&R Biofab Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. T&R Biofab Co's current OCF Margin % is -11.06%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T&R Biofab Co stock overvalued right now?
Based on GuruFocus' analysis, T&R Biofab Co (XKRX:246710) is currently considered Possible Value Trap. The stock's GF Value™ is ₩19,469.96, compared to a current price of ₩2,200.00 — trading 88.7% below its estimated fair value. The current OCF Margin % is -11.06%. T&R Biofab Co's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For T&R Biofab Co (XKRX:246710), the current OCF Margin % is -11.06% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is T&R Biofab Co (XKRX:246710) Overvalued in 2026?
Based on GuruFocus' analysis, T&R Biofab Co stock appears to be undervalued.
The current stock price of ₩2,200.00 is trading 88.7% below its estimated GF Value™ of ₩19,469.96.
GuruFocus considers T&R Biofab Co to be Possible Value Trap.
Key valuation signals for XKRX:246710:
OCF Margin %: -11.06%
GF Value™: ₩19,469.96 vs. price of ₩2,200.00 (88.7% below fair value)
No single metric tells the full story. See the XKRX:246710 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
T&R Biofab Co Ltd is a Korea based biomedical engineering company. It is mainly engaged in manufacturing bioresorbable scaffolds that aids in regeneration and reconstruction of tissues and organs using innovative 3D printing technology.
57GF Score
Get the complete analysis for XKRX:246710
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:246710 has been successfully added to your 
